Researchers have revealed an innovative DNA walker, capable of rapidly traversing a prepared track. Rather than slow, tentative steps across a surface, the DNA acrobat cartwheels head over heels, covering ground 10- to 100-fold faster than previous devices.
Cryptographic system could enable ‘crowdsourced’ genomics, with volunteers contributing information to privacy-protected databases.
A new app helps patients with muscular dystrophy control a robotic exoskeleton that assists with everyday tasks like drinking a glass of water or turning on a light switch.
Researchers have created tools that would enable real-time activation of target genes in specific locations in the genome.
Technologies for amplifying, sequencing and matching DNA have created new opportunities in genomic science. But there are ethical and social implications.
Harvard scientist, George Church is putting his efforts into using an alternative, older technology in a bid to recode an entire human genome in hundreds of thousands of locations in order to make it immune to viruses.
Deep learning computers in a diagnostic imaging lab routinely defeat their human counterparts in diagnosing heart failure, detecting various cancers and predicting their strength.
The Scripps Translational Science Institute has received over $34 million in renewed funding from the National Institutes of Health’s National Center for Advancing Translational Sciences to advance medical research and clinical care through genomic and digital technologies.
There are many different techniques for DNA and RNA amplification. By far the most common method, however, is the Polymerase Chain Reaction (PCR). This simple guide will tell you everything you need to know about PCR.
Gilead Sciences will partner with Google Parent Alphabet’s Verily Life Sciences over the next three years, applying Verily’s Immunoscape platform to better understand the immunological basis of three common diseases.
A new method for diagnosing breast cancer involves a pill, which could do a better job distinguishing between benign and aggressive tumours.
Researchers at the Broad Institute of MIT and Harvard have reported that their platform, SHERLOCK, now can be used to detect viruses directly in clinical samples such as blood or saliva.
We have achieved so much since the full human genome sequence was published for the first time, can you believe that was over fifteen years ago this month?